Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Ranbaxy (UK) Limited, 5th floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
Celiprolol hydrochloride 400 mg film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White coloured, capsule shaped, biconvex film coated tablets, debossed with ‘400’ on one side of the breakline and a deep breakline on the other side. The tablet can be divided into equal doses. |
Each tablet contains 400 mg celiprolol hydrochloride.
Each tablet contains 3.6mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Celiprolol |
Celiprolol is a vasoactive beta-l selective adrenoceptor antagonist with partial beta-2 agonist activity indicated in mild to moderate hypertension. The beta-2 agonist activity is thought to account for its mild vasodilating properties. It lowers blood pressure in hypertensive patients at rest and on exercise. |
| List of Excipients |
|---|
|
Microcrystalline cellulose Film coating material: Hypromellose |
Blister strips comprising of white opaque PVC film with a backing of aluminium foil coated with heat seal lacquer.
Pack of 10, 20, 28, 30, 50, 56 and 100 tablets.
Ranbaxy (UK) Limited, 5th floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
PL 14894/0046
27/06/2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
